Carbaril

CHEMBL46917 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
201.2 g/mol
LogP
2.4
Phase
4

Also known as carbaryl, this is a carbamate insecticide occasionally used in topical formulations to treat head lice infestations that are resistant to other agents. It inhibits the enzyme acetylcholinesterase in insects, disrupting their nervous system function. Its use in humans is limited and subject to regulatory restrictions due to potential toxicity.

分子量

201.2200 g/mol

LogP

2.40

TPSA

38.30 Ų

Lipinski 五规则

符合

作用机制

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNC(=O)Oc1cccc2ccccc12

InChI

InChI=1S/C12H11NO2/c1-13-12(14)15-11-8-4-6-9-5-2-3-7-10(9)11/h2-8H,1H3,(H,13,14)

Molecular Formula

C12H11NO2

HBD / HBA

1 / 2

可旋转键数

2

重原子数

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Also known as carbaryl, this is a carbamate insecticide occasionally used in topical formulations to treat head lice infestations that are resistant to other agents. It inhibits the enzyme acetylcholinesterase in insects, disrupting their nervous system function. Its use in humans is limited and subject to regulatory restrictions due to potential toxicity.

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

Yes, Carbaril is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL46917. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6129. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.